PMID: 9175030Jan 1, 1997Paper

Shrinking lungs syndrome in systemic lupus erythematosus: improvement with inhaled beta-agonist therapy

Lupus
F J Muñoz-RodríguezM Ingelmo

Abstract

The pathogenesis and therapy of shrinking lungs syndrome in patients with systemic lupus erythematosus remains controversial. It has been previously reported that corticosteroid treatment can be effective. We report a patient with shrinking lungs syndrome who presented a good response to inhaled beta-agonist therapy. Therapeutic approach to this syndrome is discussed.

References

Feb 1, 1990·Australian and New Zealand Journal of Medicine·W M StevensJ Webb
May 1, 1985·Journal of Applied Physiology·D Laporta, A Grassino
Apr 1, 1988·The American Review of Respiratory Disease·A Mier-JedrzejowiczM Green
Aug 1, 1988·Chest·A P AndonopoulosH M Moutsopoulos
Jul 1, 1985·Arthritis and Rheumatism·S JacobelliC Lisboa
Apr 1, 1984·Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology·M AubierR Pariente

❮ Previous
Next ❯

Citations

Oct 19, 1999·Arthritis and Rheumatism·A TavoniS Bombardieri
Nov 18, 2000·Arthritis and Rheumatism·M IshiiY Katada
Jan 20, 2000·Thorax·M P Keane, J P Lynch
Oct 12, 2010·QJM : Monthly Journal of the Association of Physicians·L A Pérez-de-LlanoA Sánchez-Andrade
Oct 17, 2006·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Ranju SinghLuis R Espinoza
Mar 11, 2010·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Helen BenhamB W Eckert
Feb 26, 2011·Expert Review of Respiratory Medicine·Delphine CarmierPatrice Diot
Jan 12, 2008·Chest·Jeffrey J SwigrisKevin K Brown
Jul 14, 2009·Best Practice & Research. Clinical Rheumatology·José María Pego-ReigosaDavid A Isenberg
Mar 1, 2009·Reumatología clinica·Delia Taverner, José A Gómez-Puerta
May 12, 2000·Mayo Clinic Proceedings·K J WarringtonW M Brutinel
Jul 1, 2008·Seminars in Arthritis and Rheumatism·Sophie P Toya, George E Tzelepis
Nov 10, 2012·Pediatric Pulmonology·Holger MeinickeMarkus Hufnagel
Jan 5, 2011·La Presse médicale·Olga Torre, Sergio Harari
Oct 19, 2001·Oncogene·S E AsplandC Murre
Mar 27, 2012·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·N PlangeK O Arend
Dec 13, 2018·Frontiers in Pharmacology·Li WuWei Wei
Apr 4, 2021·Pharmaceuticals·Salvatore Di BartolomeoFrancesco Carubbi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.